BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Habiba U, Hossain E, Yanagawa-Matsuda A, Chowdhury AFMA, Tsuda M, Zaman AU, Tanaka S, Higashino F. Cisplatin Relocalizes RNA Binding Protein HuR and Enhances the Oncolytic Activity of E4orf6 Deleted Adenovirus. Cancers (Basel) 2020;12:E809. [PMID: 32230919 DOI: 10.3390/cancers12040809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Jin KT, Du WL, Liu YY, Lan HR, Si JX, Mou XZ. Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements. Cancers (Basel) 2021;13:588. [PMID: 33546172 DOI: 10.3390/cancers13040588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhang B, Cheng P. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy. Mol Cancer 2020;19:158. [PMID: 33172438 DOI: 10.1186/s12943-020-01275-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
3 Sato-Dahlman M, Roach BL, Yamamoto M. The Role of Adenovirus in Cancer Therapy. Cancers (Basel) 2020;12:E3121. [PMID: 33114467 DOI: 10.3390/cancers12113121] [Reference Citation Analysis]
4 Ahmed I, Alam MT, Yanagawa-Matsuda A, Hossain E, Kitamura T, Minowa K, Higashino F. Enhanced oncolytic activity of E4orf6-deficient adenovirus by facilitating nuclear export of HuR. Biochem Biophys Res Commun 2020;529:494-9. [PMID: 32703457 DOI: 10.1016/j.bbrc.2020.04.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]